Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Bristol-Myers reports negative results from Phase III study of Opdivo

Histopathologic image of small cell carcinoma of the lung. Credit: KGH.

  • Lungs

Go Top